期刊文献+

GnRH-a加强黄体支持对拮抗剂方案促排卵患者鲜胚移植结局的影响

Effect of GnRH-a strengthening luteal support on the outcome of freshembryo transfer in ovulation promotion patients with antagonist regimen
原文传递
导出
摘要 目的比较传统黄体支持与使用GnRH-a加强黄体支持对拮抗剂方案促排卵患者鲜胚移植结局的影响。方法回顾性分析2018年1月至2021年5月在北京朝阳医院生殖医学中心接受拮抗剂方案促排卵行新鲜胚胎移植的患者,共183个周期。按不同黄体支持分为3组,对照组:胚胎移植后常规黄体酮支持,即单独使用肌注黄体酮(60 mg/d)持续至验孕日;研究组1:在常规黄体支持方案基础上,于取卵后第6天添加1次GnRH-a加强黄体支持;研究组2:在常规黄体支持方案基础上,于取卵后第6、8、10天添加3次GnRH-a加强黄体支持。比较3组妊娠率、继续妊娠率等治疗结局的差异。结果3组年龄、BMI、基础内分泌等比较,差异无统计学意义(P>0.05);研究组1与对照组相比,临床妊娠率增高(54.7%vs 35.5%),研究组2与对照组相比临床妊娠率升高(56.1%vs 35.5%),差异有统计学意义(P<0.05);研究组1与研究组2临床妊娠率、持续妊娠率、异位妊娠率、活产率和早期妊娠丢失率比较,差异无统计学意义(P>0.05)。结论使用GnRH-a加强黄体支持可帮助提高拮抗剂方案促排卵鲜胚移植患者妊娠率。 Objective To compare the effects of traditional luteal support and GnRH-a enhanced luteal support on the outcome of fresh embryo transfer.Methods From January 2018 to May 2021,183 cycles of fresh embryo transfer in ovulation induction patients with antagonist regimen in Reproductive Medicine Center of Bejing Chao-Yang Hospital were retrospectively analyzed.They were divided into three groups according to different luteal support.The control group received conventional progesterone support after embryo transfer,intramuscular progesterone(60 mg/d)was used alone until the pregnancy test day;Study group l:on the basis of routine luteal support regimen,GnRH-a was added once on the 6th day after transplantation to enhance luteal support.Study group 2:on the basis of routine luteal support regimen,GnRH-a was added three times on the 6th,8th day and 1Oth day after transplantation to enhance luteal support.Pregnancy rate,continued pregnancy rate and other treatment outcomes were compared among the three groups.Resulsts There were no significant differences in age,BMI and basic endocrine among the three groups(P>0.05).Compared with the control group,the clinical pregnancy rate in study group 1 was higher(54.7%vs 35.5%),and the clinical pregnancy rate in study group 2 was significantly higher(56.1%vs 35.5%),the differences were statistically significant(P<0.05).There was no significant difference in clinical pregnancy rate,persistent pregnancy rate,ectopic pregnancy rate,live birth rate and early pregnancy loss rate between study group 1 and study group 2(P>0.05).Conclusion The use of GnRH-a to enhance luteal support can improve the pregnancy rate of fresh embryo transfer patients with ovulation induction regimen.
作者 刘明慧 孙微 李媛 韩烁 Liu Minghui;Sun Wei;Li Yuan;Han Shuo(Center of Reproductive Medicine,Beijing Chao-Yang Hospital,Capital Medical University,100020 Beijing;Department of Obsletrics and Gynecology,Xiayang Street Community Health Serice Center,Qingpu District,201799 Shanghai;Department of Reproductive Medicine,Chengdu Xi-nan Gynecology Hospital,Chengdu Sichuan 610000,P.R.China)
出处 《中国计划生育和妇产科》 2023年第5期76-79,共4页 Chinese Journal of Family Planning & Gynecotokology
关键词 体外受精-胚胎移植 拮抗剂方案 黄体支持 促性腺激素释放激素激动剂 IVF-ET antagonist protocol luteal support GnRH-a
  • 相关文献

参考文献7

二级参考文献64

  • 1李洁,周灿权,钟依平,欧建平,林雯青,庄广伦.不同小剂量促性腺激素释放激素激动剂在体外受精-胚胎移植中应用的比较[J].中华妇产科杂志,2006,41(4):269-270. 被引量:39
  • 2Happ J,Schultheiss H,Jacohi GH,et al.Pharmacodynamics,Pharmacokinetics and bioavailability of prolong LH-RH agonist-SR[A].In:Klijin JGM(ed).Hormonal Manipulation of Cancermograph Series of the Eurpean Organization for Research on Treatment for Cancer[M].New York:Raven Press,1987:249.
  • 3Janssens RM,Lambalk CB,Vermeiden JP,et al.Study of triptorelin acetate for prevention of a premature LH surge in IVF:a prospective,randomized,double-blind,placebo-controlled study[J].Hum Reprod,2000,15 (11):2333-2340.
  • 4Yim SF,Lok IH,Cheng LP,et al.Dose-finding study for the use of long-acting gonadotrophin-releasing hormone analogues prior to ovarian stimulation for IVF[J].Hum Reprod,2001,16(3):492-494.
  • 5Albuquerque LE,Saconato H,Maciel MC.Depot versus daily administration of gonadotrophin releasing hormone agonist protocols for pituitary desensitization in assisted reproduction cycles[CD].Cochrane Database Syat Rev,2002,(3):CD002808.
  • 6Hanoch J,Lavy Y,Holzer H,et al.Youg low responders protected from untoward of reduced ovarian response[]].Fertil Steril,1998,69(6):1001-1004.
  • 7Fleming R,Lioyd F,Herbert M,et al.Effects of profound suppression of luteinizing hormone during ovarian stimulation on follicular activity,oocyte and embryo function in cycles stimulated with purified follicle stimulating hormone[J].Hum Reprod,1998,13(7):1788-1792.
  • 8Fowler PA,Scorsa-Leslie T,Harris W,et al.Ovarian gonadotrophin surge-attenuating factor (GnSAF):Where are we after 20 years of research?[J].J Reprod,2003,126(6):689-699.
  • 9Choi JH,Gilks CB,Leung PC,et al.Immunolocalization of gonadotropin-releasing hormone (GnRH)-Ⅰ,GnRHoⅡ,and Type Ⅰ GnRH receptor during follicular development in the human ovary[J].J Clin Endocrinol Metab,2006,91 (11):4562-4570.
  • 10Takahashi K,Karino K,Kanasaki H,et al.Altered kinetics of pituitary response to gonadotropin-releasing hormone in women with variant luteinizing hormone:correlation with ovulatory disorders[J].Horm Res,2004,61(1):27-32.

共引文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部